Advances in myopia control strategies for children

角膜塑形术 医学 阿托品 心理干预 验光服务 眼科 折射误差 眼病 内科学 角膜 精神科
作者
Xiu Juan Zhang,Ebenezer Zaabaar,Amanda Nicole French,Fang Yao Tang,Ka Wai Kam,Clement Chee Yung Tham,Li Jia Chen,Chi Pui Pang,Jason C. S. Yam
出处
期刊:British Journal of Ophthalmology [BMJ]
卷期号:109 (2): 165-176 被引量:94
标识
DOI:10.1136/bjo-2023-323887
摘要

Myopia has long been a global threat to public health. Timely interventions are likely to reduce the risk of vision-threatening complications. There are both established and rapidly evolving therapeutic approaches to slow myopia progression and/or delay its onset. The effective methods for slowing myopia progression include atropine eye-drops, defocus incorporated multiple segments (DIMS) spectacle lenses, spectacle lenses with highly aspherical lenslets target (HALT), diffusion optics technology (DOT) spectacle lenses, red light therapy (RLT), multifocal soft contact lenses and orthokeratology. Among these, 0.05% atropine, HALT lenses, RLT and +3.00 peripheral addition soft contact lenses yield over 60% reduction in myopia progression, whereas DIMS, DOT and MiSight contact lenses demonstrate at least 50% myopia control efficacy. 0.05% atropine demonstrates a more optimal balance of efficacy and safety than 0.01%. The efficacy of 0.01% atropine has not been consistent and requires further validation across diverse ethnicities. Combining atropine 0.01% with orthokeratology or DIMS spectacles yields better outcomes than using these interventions as monotherapies. Increased outdoor time is an effective public health strategy for myopia prevention while recent studies suggest that 0.05% low-concentration atropine and RLT therapy have promising potential as clinical myopia prevention interventions for high-risk groups. Myopia control spectacle lenses, being the least invasive, are safe for long-term use. However, when considering other approaches, it is essential to ensure proper instruction and regular follow-ups to maintain safety and monitor any potential complications. Ultimately, significant advances have been made in myopia control strategies, many of which have shown meaningful clinical outcomes. However, regular use and adequate safety monitoring over extended durations are imperative to foster confidence that can only come from extensive clinical experience.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Moonber发布了新的文献求助10
刚刚
Linus完成签到,获得积分10
1秒前
千空发布了新的文献求助10
2秒前
2秒前
2秒前
干就完发布了新的文献求助10
2秒前
钟梓袄发布了新的文献求助10
2秒前
任我完成签到,获得积分10
2秒前
2秒前
Chelseacyh发布了新的文献求助10
3秒前
3秒前
孟滴滴的应助被颜凡桃采纳,获得10
3秒前
3秒前
领导范儿的应助被灰灰采纳,获得10
3秒前
ccl完成签到,获得积分10
3秒前
Owen的应助被KX采纳,获得10
4秒前
吴赫轩完成签到,获得积分20
4秒前
烟花的应助被Miraitowa采纳,获得10
4秒前
5秒前
糖淘淘发布了新的文献求助10
5秒前
Lisa的应助被chi采纳,获得10
5秒前
5秒前
1234567发布了新的文献求助10
5秒前
xokey发布了新的文献求助10
5秒前
我是谁的应助被李晨语采纳,获得20
5秒前
爱科研的赛的应助被李晨语采纳,获得10
6秒前
6秒前
6秒前
6秒前
救救太阳发布了新的文献求助10
6秒前
赘婿的应助被顺利毕业采纳,获得10
7秒前
乐乐的应助被香辣土豆丝采纳,获得10
7秒前
深情安青的应助被zhl采纳,获得10
7秒前
blue发布了新的文献求助10
8秒前
11完成签到,获得积分10
8秒前
榛子田发布了新的文献求助10
9秒前
希望天下0贩的0的应助被H11103y采纳,获得10
9秒前
renpp822发布了新的文献求助10
9秒前
仁爱的怜南完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572434
关于积分的说明 21825655
捐赠科研通 7779988
什么是DOI,文献DOI怎么找? 3433852
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480148